UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (MRUS) (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback